Prostatis Group Portfolio holdings
Top Buys
Top Sells
Sector Composition
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.25% |
| 3 | Consumer Discretionary | 0.99% |
| 4 | Communication Services | 0.97% |
| 5 | Industrials | 0.79% |
Similar funds
Prostatis Group's Q1 2020 Portfolio in Review
As of Q1 2020, Prostatis Group held 96 positions worth $70.4M, down 36% from $111M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Prostatis Group withdrew a net $33.9M in Q1 2020, closing 39 positions and reducing 21 holdings. Its most notable exit was Vanguard S&P 500 ETF, an estimated $12.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.5% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Prostatis Group opened a new position in iShares 5-10 Year Investment Grade Corporate Bond ETF worth $4.56M.
- Prostatis Group's largest Q1 2020 buy was iShares 5-10 Year Investment Grade Corporate Bond ETF: 82,996 shares worth $4.56M.
- Prostatis Group added most to abrdn Physical Gold Shares ETF in Q1 2020, an estimated $7.09M increase.
- Prostatis Group's biggest Q1 2020 reduction was Fidelity MSCI Real Estate Index ETF, cutting an estimated $2.02M.
- Prostatis Group fully exited Vanguard S&P 500 ETF in Q1 2020, selling an estimated $12.7M.
- Prostatis Group's ten largest holdings make up 62% of its $70.4M portfolio in Q1 2020.
- Prostatis Group opened 18 new positions and closed 39 in Q1 2020.
- Prostatis Group's portfolio value fell 36% quarter-over-quarter to $70.4M.
Based on Prostatis Group's 13F filing for Q1 2020, filed 23 Mar 2023.